Related Experiment Video
Updated: Jun 19, 2026

Endoscopy Guided Photoablation of Endometrial Cysts using a 980 nm Laser with a Contact Fiber in Mares
Published on: July 16, 2020
EpiLASIK with mitomycin C
Christoph Winkler von Mohrenfels1, Ramin Khoramnia, Mathias Maier
1Augenklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany. christoph.wvm@web.de
Purpose:
Mitomycin C after photorefractive keratectomy (PRK) is used to reduce the development of haze and regression in higher intended corrections. The aim of this study was to investigate the safety, stability, and efficacy of EpiLASIK with mitomycin C.
Methods:
Fifty eyes of 29 patients underwent EpiLASIK with the Gebauer EpiLift microkeratome. The mean preoperative spherical equivalent was -6.89 D (SD +/-0.63, range -6.0 to -8.0 D). After the laser ablation, mitomycin C 0.02% was applied for 30 seconds on a sterile filter paper. Preoperatively and 1, 3, 6, and 12 months after surgery, a full ophthalmic examination was performed.
Results:
In 42 of 50 eyes, the bandage contact lens was removed at day 3. Twelve months after surgery, 96% of all eyes were within +/-1.0 D and 82% were within +/-0.5 D of intended correction. Five percent of all patients lost 1 line of best-corrected Snellen visual acuity, 42% were stable, and 56% gained 1 or more lines. In most patients, the cornea was clear during the whole follow-up, and in 10% only trace haze was visible. The uncorrected visual acuity was at least 1.0 in 86% of all patients, and all patients reached 0.5.
Conclusions:
EpiLASIK with mitomycin C with higher intended corrections seems to be an effective and safe procedure. With the application of mitomycin C, only minimal haze appears.
Insights
EpiLASIK with mitomycin C is a safe and effective procedure for higher myopia corrections, resulting in minimal haze and good visual outcomes. This treatment helps reduce haze and regression after laser eye surgery.
Area of Science:
- Ophthalmology
- Refractive Surgery
- Corneal Surgery
Background:
- Photorefractive keratectomy (PRK) often uses mitomycin C to prevent haze and regression in high myopia.
- EpiLASIK is an advanced surface ablation technique.
Purpose of the Study:
- To evaluate the safety, stability, and efficacy of EpiLASIK combined with mitomycin C.
- To assess outcomes for patients with higher intended refractive corrections.
Main Methods:
- Fifty eyes of 29 patients underwent EpiLASIK using the Gebauer EpiLift microkeratome.
- Mitomycin C (0.02%) was applied for 30 seconds post-ablation.
- Ophthalmic examinations were conducted preoperatively and at 1, 3, 6, and 12 months post-surgery.
Main Results:
- Twelve months post-surgery, 82% of eyes achieved within +/-0.5 D of intended correction.
- 86% of patients achieved uncorrected visual acuity of 1.0 or better.
- Only 10% of patients showed trace haze, with most corneas remaining clear.
Conclusions:
- EpiLASIK with mitomycin C is a safe and effective procedure for correcting higher myopia.
- The use of mitomycin C minimizes corneal haze development.
- The procedure demonstrates good visual stability and efficacy.
More Related Videos
05:52Drosophila Embryo Preparation and Microinjection for Live Cell Microscopy Performed using an Automated High Content Analyzer
Published on: January 19, 2021
08:13Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Mitosis and Cytokinesis
The processes of the cell cycle occur over approximately 24 hours (in typical human cells) and in two major distinguishable stages. The...
Mitogens and the Cell Cycle
Anaphase Promoting Complex